Primary |
Computerised Tomogram |
46.3% |
Computerised Tomogram Abdomen |
11.9% |
Computerised Tomogram Thorax |
6.2% |
Angiogram |
5.9% |
Drug Use For Unknown Indication |
4.8% |
Premedication |
3.1% |
Computerised Tomogram Head |
2.3% |
Product Used For Unknown Indication |
2.3% |
Urogram |
2.3% |
Arteriogram Coronary |
1.9% |
Percutaneous Coronary Intervention |
1.9% |
Hypertension |
1.7% |
Scan Brain |
1.7% |
Therapeutic Embolisation |
1.7% |
Volume Blood |
1.5% |
Pain |
1.1% |
Cervix Carcinoma |
0.9% |
Gastric Ulcer |
0.9% |
Prinzmetal Angina |
0.9% |
Angina Pectoris |
0.8% |
|
Urticaria |
13.2% |
Nephropathy Toxic |
11.7% |
Vomiting |
9.7% |
Shock |
7.2% |
Throat Tightness |
7.2% |
Anaphylactic Shock |
6.6% |
Rash |
4.6% |
Throat Irritation |
4.3% |
Wheezing |
4.3% |
Drug Administration Error |
4.0% |
Sneezing |
4.0% |
Tremor |
3.7% |
Dyspnoea |
2.9% |
Anaphylactic Reaction |
2.6% |
Pruritus |
2.6% |
Renal Failure Acute |
2.6% |
Cardio-respiratory Arrest |
2.3% |
Hypersensitivity |
2.3% |
Loss Of Consciousness |
2.3% |
Nausea |
2.0% |
|
Secondary |
Product Used For Unknown Indication |
22.8% |
Computerised Tomogram |
10.6% |
Therapeutic Embolisation |
8.9% |
Computerised Tomogram Abdomen |
8.1% |
Arthrogram |
7.3% |
Bronchopneumonia |
6.5% |
Percutaneous Coronary Intervention |
6.5% |
Angiogram |
5.7% |
Computerised Tomogram Thorax |
4.9% |
Gastric Ulcer |
4.9% |
Hypertension |
3.3% |
Blood Pressure |
2.4% |
Angina Pectoris |
1.6% |
Ovarian Cancer |
1.6% |
Adrenal Mass |
0.8% |
Blood Cholesterol |
0.8% |
Cardiac Failure |
0.8% |
Endoscopy Upper Gastrointestinal Tract |
0.8% |
Nuclear Magnetic Resonance Imaging |
0.8% |
Prophylaxis |
0.8% |
|
Unresponsive To Stimuli |
17.1% |
Vomiting |
11.4% |
Hypothyroidism |
8.6% |
Renal Failure |
8.6% |
White Blood Cell Count Increased |
8.6% |
Gaze Palsy |
5.7% |
Renal Failure Acute |
5.7% |
Anaphylactic Reaction |
2.9% |
Bladder Catheterisation |
2.9% |
Eye Movement Disorder |
2.9% |
Feeling Abnormal |
2.9% |
Haemorrhagic Cerebral Infarction |
2.9% |
Incorrect Route Of Drug Administration |
2.9% |
Injection Site Swelling |
2.9% |
Pneumonia |
2.9% |
Pulmonary Embolism |
2.9% |
Rash |
2.9% |
Tremor |
2.9% |
Urticaria |
2.9% |
|
Concomitant |
Product Used For Unknown Indication |
34.1% |
Drug Use For Unknown Indication |
7.0% |
Arthralgia |
5.2% |
Coronary Artery Bypass |
4.8% |
Catheterisation Cardiac |
4.6% |
Computerised Tomogram |
3.5% |
Constipation Prophylaxis |
3.5% |
Decreased Appetite |
3.5% |
Excoriation |
3.5% |
Hepatic Neoplasm Malignant |
3.5% |
Hepatitis B |
3.5% |
Stomatitis |
3.5% |
Vomiting |
3.5% |
Angiogram |
2.8% |
Diabetes Mellitus |
2.6% |
Nasopharyngitis |
2.6% |
Aortic Valve Replacement |
2.2% |
Blood Pressure Abnormal |
2.2% |
Cardiac Disorder |
2.2% |
Hypertension |
1.7% |
|
Injury |
11.3% |
Anhedonia |
9.4% |
Emotional Distress |
7.5% |
Retinal Vascular Disorder |
7.5% |
Retinal Vascular Thrombosis |
7.5% |
Tubulointerstitial Nephritis |
7.5% |
Unevaluable Event |
7.5% |
Ventricular Extrasystoles |
7.5% |
Fear |
5.7% |
Renal Failure |
5.7% |
Pain |
3.8% |
Stress |
3.8% |
Depression |
1.9% |
Mental Disorder |
1.9% |
Musculoskeletal Chest Pain |
1.9% |
Rash |
1.9% |
Renal Failure Acute |
1.9% |
Renal Impairment |
1.9% |
Renal Injury |
1.9% |
Vomiting |
1.9% |
|